CoChat

Lenvatinib May Drastically Change the Treatment Landscape of Hepatocellular Carcinoma

Open access
Kudo, Masatoshi · 2018 · Liver Cancer
Cited by 135

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

Ongoing 11.Sorafenib vs. durvalumab vs. durvalumab + tremelimumab HIMALAYA Ongoing Second line 1.Brivanib vs. placebo

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1159/000487148

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 135

Metadata

Authors
Kudo, M.
Venue
Liver Cancer
Publisher
S. Karger AG
Published
2018
Volume
7
Issue
1
Pages
1-19
ISSN
  • 1664-5553 (ISSN-L)
  • 2235-1795
OpenAlex
W2789297669
Cited by
135
References
10
FWCI
8.27
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Lenvatinib May Drastically Change the Treatment Landscape of Hepatocellular Carcinoma. https://app.cochat.ai/papers/10.1159/000487148
The paper
Kudo, M. (2018). Lenvatinib May Drastically Change the Treatment Landscape of Hepatocellular Carcinoma. Liver Cancer. https://doi.org/10.1159/000487148

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.